JUSLINA D 5/10 TABLET is a combination of Dapagliflozin and Linagliptin, which belongs to the group of medicines called Antidiabetic agents. It is used for the management of patients with type 2 diabetes mellitus who are inadequately controlled on metformin monotherapy.

Type II diabetes mellitus is a chronic disease characterized by abnormally high levels of glucose in the blood. It is caused by inadequate production of a hormone called insulin (produced by the pancreas to metabolize glucose) in the body or by inadequate sensitivity of body cells to the actions of insulin.

Before starting management with JUSLINA D 5/10 TABLET, your doctor will assess your volume status and kidney function by conducting a blood test. JUSLINA D 5/10 TABLET should be used with caution in patients with liver disease, heart failure, and low blood pressure. Consult your doctor before taking it.

Inform your doctor before taking this medicine if you are pregnant, think you may be pregnant, or are planning to have a baby. JUSLINA D 5/10 TABLET is not recommended for use by breastfeeding women as it is not known whether it may pass through breast milk. Consult your doctor for advice.

The most common side effects of taking JUSLINA D 5/10 TABLET are hypoglycemia, vulvovaginitis, balanitis and related genital infections, urinary tract infections, dizziness, rash, and back pain. Consult your doctor if any of the side effects worsen.